Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-catenin

1 Citations 50 References
  • KURODA Junya
    Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine
  • KAMITSUJI Yuri
    Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine
  • KIMURA Shinya
    Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital
  • ASHIHARA Eishi
    Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital
  • KAWATA Eri
    Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine
  • NAKAGAWA Yoko
    Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital
  • TAKEUICHI Miki
    Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital
  • MUROTANI Yoshihide
    Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital
  • YOKOTA Asumi
    Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital
  • TANAKA Ruriko
    Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital
  • ANDREEFF Michael
    Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas, M. D. Anderson Cancer Center
  • TANIWAKI Masafumi
    Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine
  • MAEKAWA Taira
    Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital

Search this article

Journal

Citations (1)*help

See more

References(50)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top